Obesity Paradox in Patients With Non–Small Cell Lung Cancer Treated With Immunotherapy-Reference-Cited by-同舟云学术

Obesity Paradox in Patients With Non–Small Cell Lung Cancer Treated With Immunotherapy

Published:2020-06-01 Issue:6 Volume:6 Page:940
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Sanchez Alejandro¹,Furberg Helena²

Affiliation:

1. Huntsman Cancer Institute, Division of Urology, University of Utah, Salt Lake City, Utah

2. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2764900/jamaoncology_sanchez_2020_le_200019.pdf

Reference5 articles.

1. Association between body mass index and overall survival with immune checkpoint inhibitor therapy for advanced non–small cell lung cancer;Kichenadasse;JAMA Oncol

2. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade.;Wang;Nat Med,2019

3. Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.;Sanchez;Lancet Oncol,2020

4. The obese adipose tissue microenvironment in cancer development and progression.;Quail;Nat Rev Endocrinol,2019

5. Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS Study).;Caan;Cancer Epidemiol Biomarkers Prev,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LRP11 promotes stem-like T cells via MAPK13-mediated TCF1 phosphorylation, enhancing anti-PD1 immunotherapy;Journal for ImmunoTherapy of Cancer;2024-01

2. Association of systemic inflammation with the obesity paradox in cancer: results from multi-cohort studies;Inflammation Research;2023-12-12

3. Impact of Baseline Clinical Biomarkers on Treatment Outcomes in Patients With Advanced NSCLC Receiving First-line Pembrolizumab-Based Therapy;Clinical Lung Cancer;2022-07

4. The Obesity Paradox in Cancer: Is Bigger Better?;Journal of Cachexia, Sarcopenia and Muscle;2022-05-04

5. Nutritional Status as a Predictive Biomarker for Immunotherapy Outcomes in Advanced Head and Neck Cancer;Cancers;2021-11-18